ATE48612T1 - Konjugate von adenin-9-beta-arabinofuranosid-5'monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. - Google Patents

Konjugate von adenin-9-beta-arabinofuranosid-5'monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Info

Publication number
ATE48612T1
ATE48612T1 AT85115802T AT85115802T ATE48612T1 AT E48612 T1 ATE48612 T1 AT E48612T1 AT 85115802 T AT85115802 T AT 85115802T AT 85115802 T AT85115802 T AT 85115802T AT E48612 T1 ATE48612 T1 AT E48612T1
Authority
AT
Austria
Prior art keywords
arabinofuranoside
monophosphate
adenine
conjugates
beta
Prior art date
Application number
AT85115802T
Other languages
English (en)
Inventor
Luigi Fiume
Corrado Busi
Alessandro Mattioli
Massimo Baldacci
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Application granted granted Critical
Publication of ATE48612T1 publication Critical patent/ATE48612T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
AT85115802T 1984-12-11 1985-12-11 Konjugate von adenin-9-beta-arabinofuranosid-5'monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. ATE48612T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23998/84A IT1177381B (it) 1984-12-11 1984-12-11 Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive
EP85115802A EP0184838B1 (de) 1984-12-11 1985-12-11 Konjugate von Adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem Albumin, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATE48612T1 true ATE48612T1 (de) 1989-12-15

Family

ID=11211397

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85115802T ATE48612T1 (de) 1984-12-11 1985-12-11 Konjugate von adenin-9-beta-arabinofuranosid-5'monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Country Status (9)

Country Link
US (1) US4794170A (de)
EP (1) EP0184838B1 (de)
JP (1) JPH0633320B2 (de)
AT (1) ATE48612T1 (de)
AU (1) AU576923B2 (de)
CA (1) CA1252719A (de)
DE (2) DE3574707D1 (de)
ES (1) ES8704945A1 (de)
IT (1) IT1177381B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1207507B (it) * 1985-10-21 1989-05-25 Baldacci Lab Spa Coniugato della 9-(2-idrossietossimetil)guanina con albumina umana lattosaminata, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
IT1245217B (it) * 1991-03-12 1994-09-13 Baldacci Lab Spa Coniugato di azidotimidina ed albumina umana procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IT1256110B (it) * 1992-11-23 1995-11-28 Procedimento di coniugazione di nucleosidi antivirali con albumina umana lattosaminata
ITMI20010027A1 (it) * 2001-01-10 2002-07-10 Uni Di Bologna Dipartimento Di Composizioni teraputiche per una chemioterapia locoregionale non invasiva delle micrometastasi epatiche
DE602004017290D1 (de) * 2003-02-17 2008-12-04 Novozymes Biopharma Uk Ltd Konjugate für medizinische abbildungen umfassend träger, targeting-anteile und kontrastmittel

Also Published As

Publication number Publication date
IT1177381B (it) 1987-08-26
ES8704945A1 (es) 1987-05-01
AU576923B2 (en) 1988-09-08
AU5118685A (en) 1986-06-19
ES549828A0 (es) 1987-05-01
JPH0633320B2 (ja) 1994-05-02
EP0184838B1 (de) 1989-12-13
EP0184838A3 (en) 1987-04-29
JPS61171430A (ja) 1986-08-02
DE3574707D1 (de) 1990-01-18
DE184838T1 (de) 1987-03-19
IT8423998A1 (it) 1986-06-11
IT8423998A0 (it) 1984-12-11
CA1252719A (en) 1989-04-18
US4794170A (en) 1988-12-27
EP0184838A2 (de) 1986-06-18

Similar Documents

Publication Publication Date Title
HUT60512A (en) Process for producing polyethylene glycol conjugates of proteins
IL83684A0 (en) Arylcarboxylic acid derivatives,their preparation and their use as fungicides
DZ613A1 (fr) Nouveaux dérivés de l'éthanol, leur préparation etleur utilisation comme fongicides.
FI102836B1 (fi) Menetelmä glykosaminoglykaanilla muunnetun proteiinin valmistamiseksi
ATE48612T1 (de) Konjugate von adenin-9-beta-arabinofuranosid-5'monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3781652D1 (de) Zubereitung, geeignet fuer die behandlung von darmstoerungen.
FI891718A0 (fi) Foerfarande foer att befria cellblandningar och vaevnader av icke-oenskade populationer.
ATE149507T1 (de) Lösliche, nichttoxische derivate von basischen polyenmakroliden, ihre herstellung und verwendung
CA2027341A1 (en) Process for the preparation of 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic acid and its derivatives
EP0599142A2 (de) Verfahren zur Herstellung von Immunkonjugaten
OA09794A (fr) Dérivés de pyridone amino acide azetidinyl substitués, leur préparation et leur application en tant que médicaments.
DE4033714C2 (de)
PT84130A (fr) Procede de preparation de nouveaux derives de 3-alkoxyflavones et de leurs compositions therapeutiques
ATE112276T1 (de) Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ES2077785T3 (es) Monomero de terc-butiloxicarbonil-l-tirosil-peptidoglucano y derivados de 125i-marcados del mismos, su preparacion y uso.
ATE60778T1 (de) Oligosaccharide, verfahren zu ihrer herstellung und ihre anwendung.
ES2004734A6 (es) Procedimiento de obtencion de conjugados biologicamente activos de metaloproteina-albumina o metaloproteina-albumina-anticuerpos
FR2658191B1 (fr) Nouveaux derives de l'acide aminopimelique et de l'acide diaminopimelique, leur procede de preparation et leur application comme medicaments.
PT99146A (pt) Processo para a preparacao de complexos de inclusao com silibinina e de composicoes farmaceuticas que os contem
FR2350845A1 (fr) Produit conjugue pour la suppression des anticorps reaginiques a la penicilline et sa preparation
RU93053897A (ru) Комплексы бициклополиазамакроциклокарбоновых кислот, их конъюгаты, фармацевтическая композиция, способ диагностики, набор и способ получения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee